diaPatch™ uses microneedles technology to extract interstitial fluid from the pelvic region and a novel assay to detect biomarkers in this fluid
diaPatch™ screens and detects -
CIN II Biomarkers
CIN III Biomarkers
What Makes diaPatch™ Great?
diaPatch™ combines microneedles with a novel assay to sample and detect cervical cancer biomarkers with high sensitivity and quick results that can be given by the end of the clinical visit.
Seamless and effortless integration into busy, modern lifestyles, allows for streamlined, higher quality patient care during the annual women's wellness visit or consult with a family medicine practitioner, gynecologist, or gynecologic oncologist.